Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
4.400
-0.050 (-1.12%)
At close: Dec 5, 2025, 4:00 PM EST
4.440
+0.040 (0.91%)
After-hours: Dec 5, 2025, 7:51 PM EST
Anavex Life Sciences Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| Selling, General & Admin | 13.95 | 11.16 | 12.16 | 13.14 | 9.15 | |
| Research & Development | 36.81 | 39.42 | 40.88 | 34.52 | 28.31 | |
| Operating Expenses | 50.76 | 50.59 | 53.05 | 47.66 | 37.46 | |
| Operating Income | -50.76 | -50.59 | -53.05 | -47.66 | -37.46 | |
| Interest & Investment Income | 4.68 | 7.32 | 6.52 | 0.95 | 0.03 | |
| Currency Exchange Gain (Loss) | -0.33 | 0.19 | -0.04 | -0.9 | -0.27 | |
| Other Non Operating Income (Expenses) | 0.04 | 0.08 | -0.94 | - | 0.05 | |
| EBT Excluding Unusual Items | -46.38 | -43 | -47.51 | -47.62 | -37.64 | |
| Pretax Income | -46.38 | -43 | -47.51 | -47.62 | -37.64 | |
| Income Tax Expense | - | - | - | 0.36 | 0.27 | |
| Net Income | -46.38 | -43 | -47.51 | -47.98 | -37.91 | |
| Net Income to Common | -46.38 | -43 | -47.51 | -47.98 | -37.91 | |
| Shares Outstanding (Basic) | 85 | 83 | 80 | 77 | 70 | |
| Shares Outstanding (Diluted) | 85 | 83 | 80 | 77 | 70 | |
| Shares Change (YoY) | 2.18% | 4.61% | 3.74% | 10.18% | 19.95% | |
| EPS (Basic) | -0.54 | -0.52 | -0.60 | -0.62 | -0.54 | |
| EPS (Diluted) | -0.54 | -0.52 | -0.60 | -0.62 | -0.54 | |
| EBIT | -50.76 | -50.59 | -53.05 | -47.66 | -37.46 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.